Cytek Biosciences, Inc.

NASDAQ:CTKB

6.83 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 0.94-10.434-6.1695.503-6.456-4.388-6.8073.7181.626-0.702-2.158-1.1651.422.670.1025.5996.548.111-0.839
Depreciation & Amortization 2.8092.482.462.4252.5592.4451.8011.8640.7711.5541.470.6850.1890.2010.1670.1580.1790.1610.105
Deferred Income Tax 000-5.7172.98-2.022000000.1550.07-0.0580.2810000
Stock Based Compensation 7.0537.1525.645.6695.7585.9224.6994.4654.3593.9343.8373.0082.4550.6670.4560.2710.1260.1090.105
Change In Working Capital -9.9548.1071.847-3.839-5.269-5.0943.693-4.74-14.999-14.988-5.2012.007-3.412-7.7980.5574.745-5.056-8.5651.34
Accounts Receivables -6.2525.9184.2350.263-6.85-6.86.055-7.964-3.816-6.926-1.038-0.72-5.593-8.292.2361.148-4.906-1.5715.663
Change In Inventory 3.5564.4264.7736.333-1.8883.029-3.1881.884-5.182-8.434-5.921-2.23-0.964-0.26-3.614-0.283-0.9350.077-4.563
Change In Accounts Payables 2.228-0.5190.615-1.7941.709-2.0040.305-0.908-0.9070.8952.782-0.7420.635-0.2610.1121.608-1.6130.231-0.281
Other Working Capital -9.486-1.718-7.776-8.6411.760.6810.5212.248-5.0942.017-1.0245.6992.511.0131.8232.2722.398-7.3020.521
Other Non Cash Items 12.3731.1861.1165.471-3.8110.287-0.5280.8860.7390.5490.5720.7580.4390.4040.3720.8680.4020.0630.734
Operating Cash Flow 13.2216.2043.9579.512-4.239-2.852.8586.193-7.504-9.44-1.485.4481.161-3.9141.93511.6412.191-0.1211.445
Investing Activities:
Investments In Property Plant And Equipment -0.808-1.201-0.622-1.561-1.393-1.368-0.505-6.53-1.15-1.328-0.78-1.296-1.308-1.251-0.509-0.203-0.474-0.522-0.348
Acquisitions Net -0.0760.0760-0.236-0.001-10-45.130000-170.37100.3710000
Purchases Of Investments -52.827-36.853-77.132-23.137-23.482-5.842-123.239-44.4540-1.587000000000
Sales Maturities Of Investments 3840725468100.235000000000000
Other Investing Activites -0.0983.075-0.05530.56744.6910-0.235-0.08-0.04-1.5870-20.9930000000
Investing Cash Flow -15.8092.022-5.75429.06643.1242.79-168.874-51.064-1.15-2.915-0.78-18.296-1.308-1.251-0.138-0.203-0.474-0.522-0.348
Financing Activities:
Debt Repayment -0.135-0.1421.255-0.14-0.138-0.141-0.1462.93300000000-1.3100
Common Stock Issued 01.2310.506000.4830.20300.9910.4460.3640.017217.078-0.9510.1870000
Common Stock Repurchased -11.95-2.67-0.148-34.742-8.428-0.981-0.0570-0.071-0.067000000000
Dividends Paid 0000000000000000000
Other Financing Activities 0.001-0.130.3581.1280.2920.3570.1460.9170.1551.1440.3640.017217.078-3.7230.187119.7270.0954.0820.013
Financing Cash Flow -12.084-1.7111.613-33.754-8.2740.2160.2033.850.1551.1440.3640.017217.078-3.7230.187119.727-1.2154.0820.013
Other Information:
Effect Of Forex Changes On Cash -0.9432.2621.695-0.8231.474-1.006-1.09-1.0020.128-1.401-0.2160.678-0.0060.150.481-0.574-0.296-0.2350.518
Net Change In Cash -15.6158.7771.5114.00132.085-0.85-167.106-42.023-8.371-12.612-2.112-12.153216.925-8.7382.465130.5910.2063.2041.628
Cash At End Of Period 162.303177.918169.141167.63163.629131.544132.394299.5341.523349.894362.506364.618376.771159.846168.584166.11935.52835.32232.118